These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party. Br J Cancer; 1990 Apr; 61(4):495-6. PubMed ID: 2184877 [No Abstract] [Full Text] [Related]
3. Controversy in treatment of advanced ovarian cancer. Scambia G; Salutari V; Amadio G Lancet Oncol; 2013 Sep; 14(10):920-1. PubMed ID: 23993374 [No Abstract] [Full Text] [Related]
4. Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer? Gurbuz A; Karateke A; Kabaca C; Kir G; Cetingoz E Int J Gynecol Cancer; 2006; 16 Suppl 1():307-12. PubMed ID: 16515610 [TBL] [Abstract][Full Text] [Related]
5. Living Through Ovarian Cancer Treatment: Acute and Long-Term Toxicities of Chemotherapy for Advanced-Stage Disease. Gockley A; Wright A Hematol Oncol Clin North Am; 2018 Dec; 32(6):1073-1085. PubMed ID: 30390761 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree? Vergote I; du Bois A; Amant F; Heitz F; Leunen K; Harter P Gynecol Oncol; 2013 Jan; 128(1):6-11. PubMed ID: 23006973 [No Abstract] [Full Text] [Related]
12. [Treatment outcomes for advanced ovarian cancers with peritoneal dissemination]. Oe S; Hasegawa K; Ichikawa R; Torii Y; Kato R; Komiyama S; Udagawa Y Gan To Kagaku Ryoho; 2011 Apr; 38(4):591-7. PubMed ID: 21498987 [TBL] [Abstract][Full Text] [Related]